Disease-Free Outcomes in Breast Cancer Patients
Patients who are diagnosed with stage I HR-positive breast cancer typically undergo to reduce the risk of disease recurrence, explained Reshma Jagsi, MD, DPhil, the Lawrence W. Davis…
Browsing Tag
Genetic Test
Molecular Diagnostics Market Worth $25.59 Billion by 2029 – Exclusive Report by…
Redding, California, Nov. 02, 2022 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test…
GoodCell Launches “On-The-Go” Delivering Turnkey, Onsite Onboarding for 2022 Open…
Norwalk, CT, Oct. 03, 2022 (GLOBE NEWSWIRE) -- GoodCell, a medically-actionable service to identify, track and manage chronic diseases and conditions impacting millions of Americans,…
Precision Diagnostics Market Size, $168Bn by 2028, 13.3% CAGR Lead by Genetic Tests…
New York, June 20, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Precision Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By…